comparemela.com

Nordic Congress News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mendus will participate in multiple investor and industry conferences in October and announces presentation of ALISON trial update at SITC

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: LSX.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.